Hospitals | April 05, 2026
Max Healthcare allots 57,461 equity shares under ESOP 2022
Paid-up equity capital rises to Rs 973.19 crore following allotment to eligible employees
Paid-up equity capital rises to Rs 973.19 crore following allotment to eligible employees
Rs 66 lakh acquisition will support DNA engineering and novel cell-gene therapy alternatives to conventional chemotherapy
As of December 31, 2025, the company reported total cash, cash equivalents and short-term investments of approximately $4.94 million
The company’s consolidated revenue from operations rose to Rs. 361.13 crore in Q2 FY26 and Rs. 707.67 crore for the first half
Valneva will consolidate its French operations at its Lyon site and close its Nantes location
Adcock Ingram has been a cornerstone of healthcare in South Africa, known for its trusted medication brands such as Panado, Myprodol, Epi-Max, Citro-soda and Allergex
Emcure Pharmaceuticals successfully completes USFDA PAI of Oncology facility
Express Scripts has added YESINTEK to the National Preferred Formulary (NPF) effective March 21, 2025
The transaction structured as share swap, is valued at ~Rs. 849 crore, with no cash outflow
He has global experience in strategic and operational leadership levels with an extensive track record of leadership and success in building companies, businesses, teams, and brands for over 30 years
Subscribe To Our Newsletter & Stay Updated
